Journal article
Brachytherapy in lung cancer: A review
Abstract
Metastatic non-small cell lung cancer (NSCLC) remains the leading cause of cancer death worldwide. Intraluminal brachytherapy (ILBT) has been shown to improve patients' symptoms in some studies. However, its role in the palliation of these patients amidst the other local treatment modalities such as external beam radiotherapy (EBRT), laser and photodynamic therapy (PDT) remains unclear. We have completed a systematic review of the literature to …
Authors
Nguyen NTA; Sur RK
Journal
Translational Cancer Research, Vol. 4, No. 4, pp. 381–396
Publication Date
August 1, 2015
DOI
10.3978/j.issn.2218-676X.2015.08.08
ISSN
2218-676X